130 related articles for article (PubMed ID: 26400343)
1. Glutathione S-transferase polymorphisms influence chemotherapy response and treatment outcome in breast cancer.
Wang J; Wang T; Yin GY; Yang L; Wang ZG; Bu XB
Genet Mol Res; 2015 Sep; 14(3):11126-32. PubMed ID: 26400343
[TBL] [Abstract][Full Text] [Related]
2. Predictive potential role of glutathione S-transferase polymorphisms in the prognosis of breast cancer.
Wang X; Huang ZH
Genet Mol Res; 2015 Aug; 14(3):10236-41. PubMed ID: 26345960
[TBL] [Abstract][Full Text] [Related]
3. Role of GSTM1, GSTT1, and GSTP1 IIe105Val gene polymorphisms in the response to chemotherapy and overall survival of advanced non-small cell lung cancer.
Jia W; Sun JY; Jia KY; Liu XC
Genet Mol Res; 2016 Sep; 15(3):. PubMed ID: 27706763
[TBL] [Abstract][Full Text] [Related]
4. Predictive potential role of glutathione S-transferases polymorphisms in response to chemotherapy and breast cancer prognosis.
Yuan P; Yuan L; Xu BL; Wang CZ; Yang HZ; Li Y
Genet Mol Res; 2015 Dec; 14(4):16675-81. PubMed ID: 26681014
[TBL] [Abstract][Full Text] [Related]
5. Association of genetic polymorphism of glutathione S-transferase (GSTM1, GSTT1, GSTP1) with bladder cancer susceptibility.
Safarinejad MR; Safarinejad S; Shafiei N; Safarinejad S
Urol Oncol; 2013 Oct; 31(7):1193-203. PubMed ID: 22154357
[TBL] [Abstract][Full Text] [Related]
6. GSTP1, GSTM1, and GSTT1 polymorphisms as predictors of response to chemotherapy in patients with breast cancer: a meta-analysis.
Kong X; Li Z; Li X
Cancer Chemother Pharmacol; 2016 Dec; 78(6):1163-1173. PubMed ID: 27785604
[TBL] [Abstract][Full Text] [Related]
7. GSTA1, GSTM1, GSTP1, and GSTT1 polymorphisms and susceptibility to smoking-related bladder cancer: a case-control study.
Matic M; Pekmezovic T; Djukic T; Mimic-Oka J; Dragicevic D; Krivic B; Suvakov S; Savic-Radojevic A; Pljesa-Ercegovac M; Tulic C; Coric V; Simic T
Urol Oncol; 2013 Oct; 31(7):1184-92. PubMed ID: 24075358
[TBL] [Abstract][Full Text] [Related]
8. Genetic polymorphisms in GST genes and survival of colorectal cancer patients treated with chemotherapy.
Funke S; Timofeeva M; Risch A; Hoffmeister M; Stegmaier C; Seiler CM; Brenner H; Chang-Claude J
Pharmacogenomics; 2010 Jan; 11(1):33-41. PubMed ID: 20017670
[TBL] [Abstract][Full Text] [Related]
9. Influence of chemotherapeutic drug-related gene polymorphisms on toxicity and survival of early breast cancer patients receiving adjuvant chemotherapy.
Ludovini V; Antognelli C; Rulli A; Foglietta J; Pistola L; Eliana R; Floriani I; Nocentini G; Tofanetti FR; Piattoni S; Minenza E; Talesa VN; Sidoni A; Tonato M; Crinò L; Gori S
BMC Cancer; 2017 Jul; 17(1):502. PubMed ID: 28747156
[TBL] [Abstract][Full Text] [Related]
10. Predictive potential role of glutathione S-transferases polymorphisms on prognosis of breast cancer.
Liu J; Luo J; Wang Y; Li L; Yang S
Int J Clin Exp Pathol; 2014; 7(12):8935-40. PubMed ID: 25674268
[TBL] [Abstract][Full Text] [Related]
11. Individual and combined effects of GSTM1, GSTT1, and GSTP1 polymorphisms on breast cancer risk: A meta-analysis and re-analysis of systematic meta-analyses.
Miao LF; Ye XH; He XF
PLoS One; 2020; 15(3):e0216147. PubMed ID: 32155154
[TBL] [Abstract][Full Text] [Related]
12. Glutathione S-transferase M1, T1 and P1 polymorphisms: susceptibility and outcome in lung cancer patients.
Sreeja L; Syamala V; Hariharan S; Syamala VS; Raveendran PB; Sivanandan CD; Madhavan J; Ankathil R
J Exp Ther Oncol; 2008; 7(1):73-85. PubMed ID: 18472644
[TBL] [Abstract][Full Text] [Related]
13. GSTT1, GSTM1, and GSTP1 polymorphisms and chemotherapy response in locally advanced breast cancer.
Oliveira AL; Rodrigues FF; Santos RE; Aoki T; Rocha MN; Longui CA; Melo MB
Genet Mol Res; 2010 Jun; 9(2):1045-53. PubMed ID: 20568049
[TBL] [Abstract][Full Text] [Related]
14. Glutathione S-transferase M1, T1, and P1 polymorphisms and survival among lung cancer patients.
Sweeney C; Nazar-Stewart V; Stapleton PL; Eaton DL; Vaughan TL
Cancer Epidemiol Biomarkers Prev; 2003 Jun; 12(6):527-33. PubMed ID: 12814998
[TBL] [Abstract][Full Text] [Related]
15. Clinical implications of glutathione S-transferase genotyping in patients with diffuse large B-cell lymphoma.
Atanaskovic L; Cikota-Aleksic B; Tarabar O; Trimcev J; Zivanovic-Ivic A; Marjanovic S; Magic Z
J BUON; 2016; 21(6):1459-1465. PubMed ID: 28039708
[TBL] [Abstract][Full Text] [Related]
16. Glutathione S-transferase gene polymorphisms (GSTM1, GSTT1, GSTP1) and prostate cancer: a case-control study in Tehran, Iran.
Safarinejad MR; Shafiei N; Safarinejad SH
Prostate Cancer Prostatic Dis; 2011 Jun; 14(2):105-13. PubMed ID: 21243008
[TBL] [Abstract][Full Text] [Related]
17. Glutathione S-Transferase Gene Polymorphisms and Treatment Outcome in Cervical Cancer Patients under Concomitant Chemoradiation.
Abbas M; Kushwaha VS; Srivastava K; Banerjee M
PLoS One; 2015; 10(11):e0142501. PubMed ID: 26571237
[TBL] [Abstract][Full Text] [Related]
18. GSTM1, GSTT1 and GSTP1 in patients with multiple breast cancers and breast cancer in association with another type of cancer.
Chirilă DN; Bălăcescu O; Popp R; Oprea A; Constantea NA; Vesa S; Ciuce C
Chirurgia (Bucur); 2014; 109(5):626-33. PubMed ID: 25375048
[TBL] [Abstract][Full Text] [Related]
19. Interaction between glutathione S-transferase M1-null/present polymorphism and adjuvant chemotherapy influences the survival of breast cancer.
Li S; Lang GT; Zhang YZ; Yu KD; Shao ZM; Zhang Q
Cancer Med; 2018 Sep; 7(9):4202-4207. PubMed ID: 30032483
[TBL] [Abstract][Full Text] [Related]
20. Genetic variability of glutathione S-transferases influences treatment outcome of breast cancer.
Zhou L; Huang A; Zhang D; Yao J; Zhang Y; Li X
Tumour Biol; 2015 Aug; 36(8):5925-9. PubMed ID: 25773389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
